Methods of cervical cancer screening and facing new problems in China
ZHANG Wen-hua

..............page:881-884

Establishment of a highly-metastatic model of human primary melanoma of the small intestine orthotopically transplanted in the small intestine of nude mice
TUO Chao-wei;ZHANG Ning;LIU Qiu-zhen;YANG Bo;WANG Ming-yao

..............page:885-890

Screening for differential methylation status by CpG island microarray in the hepatocellular carcinoma cell lines
ZHENG Dan;LIU Bin-bin;LIU Yin-kun;KANG Xiao-nan;SUN Lu;GUO Kun;SUN Rui-xia;CHEN Jie;ZHAO Yan

..............page:891-896

In vivo effect of annexin Ⅰ down-regulation on the growth of human pancreatic cancer in nude mice
LIU Qian;HU Hai;RAN Yu-liang;WANG Cheng-feng;ZHAO Dong-bing;TIAN Yan-tao;SUN Li-xin;XIE Yi-bin;YANG Zhi-hua;ZHAO Ping

..............page:897-900

FTIR spectroscopic explorations of freshly resected laryngeal carcinoma tissues
WU Zheng-hu;CUI Cai-xia;LIU Ting-yan;JIANG Jian-hua;ZHOU Xue-hua;PAN Qing-hua

..............page:901-904

Expression and clinical relevance of ARHI, STAT3 and E2F1 in ovarian serous carcinoma
ZHANG Jun;LI Yue-hong;CUI Ai-rong;WANG Jun-ling;CHENG Jian-xin;WANG Shi-jie

..............page:905-909

Application of SELDI-TOF-MS in detection of liver metastasis from colorectal cancer
SHI Yi-jiu;ZHAO Yun;XU Jian-min;LAI Yan-han;YU Xin-zhe;ZHONG Yun-shi;WEI Ye;REN Li;ZHU De-xiang;LIU Yin-kun;NIU Wei-xin;QIN Xin-yu

..............page:910-913

Comparison between pathological findings and MR diffusion-weighted imaging in primary hepatocellular carcinoma after transcatheter arterial chemoembolization
XIAO Yun-ping;XIAO En-hua;LUO Jian-guang;BIAN Du-jun;LI Mo-qiu;HE Zhong;SHANG Quan-liang;LIANG Bin

..............page:914-916

Clinicopathological characteristics and prognostic factors of breast cancer with estrogen-and progesterone-receptor negative and HER-2 overexpression
FAN Ying;GUAN Yin;ZHAO Wei-hong;LI Qing;XU Bing-he

..............page:917-920

Cox proportional hazard model analysis of prognosis in patients with carcinoma of esophagus and gastric cardia after radical resection
LIU Wei;HAO Xi-shan;FAN Qian;LI Hai-xin;SONG Li-nan;WANG Shi-jie;WANG Pei-zhong;JIN Ying;CHEN Yong;GUAN Li-yun;PING Yu-min;MENG Xian-li;WANG Rui;LIU Jun-feng;WANG Xiao-ling

..............page:921-925

Clinical analysis of 81 cases with primary small cell carcinoma of the esophagus
ZHAN Xiao-kai;SUN Yong-kun;ZHANG Wen;WANG Jin-wan

..............page:926-929

Detection of serum CK19-2G2 and Cyfra21-1 protein and comparison of their diagnostic value for lung cancer
GAO Jia;WANG Hai;QI Jun

..............page:930-932

The role of 18SF-FDG DHC SPECT-CT in the diagnosis and staging for lung cancer
MAO You-sheng;HE Jie;ZHENG Rong;LIN Lin;LIU Lin;CHENG Zhao

..............page:933-936

Nedaplatin combined with tegafur in the treatment for advanced esophageal cancer
FAN Qing-xia;WANG Rui;LU Ping;ZHAO Yong-fu;LU Tai-ying;HAN Jian-wei;WANG Jun-sheng;LUO Su-xia;LU Shou-ping;WANG Gui-ji;GENG Li;ZHANG Ming-zhi;MA Zhi-yong;SONG Min;WU Xin-ai;CHEN Xiao-bing;JIAO Zhi-min;WANG Rui-lin

..............page:937-939

Capecitabine combined with cisplatin as first-line therapy in Chinese patients with advanced gastric carcinoma-a phase Ⅱ clinical study
HU Bing;YU Ji-ren;WEN Zhao-zhang;SHU Yong-qian;WANG Bao-cheng;YIN Hao-ran;CHEN Li;BAI Yu-xian;LIANG Jun;CHEN Li;CHENG Ying;SHEN Lin;ZHOU Yun;ZHANG Hong-gang;LI Jie;WAN De-sen;CHEN Shuang;JIA Ting-zhen;JIN Mao-lin

..............page:940-943

Docetaxel and capecitabine combination chemotherapy for patients with anthracycline-resistant metastatic breast cancer
LI Shu-fen;WANG Xu;WANG Chen;HE Li-hong;Shi Ye-hui;HAO Chun-fang;DONG Guo-lei;TONG Zhong-sheng

..............page:944-946

Understanding and controversy of the gastroesophageal junction adenocarcinoma
ZHANG Xiang-hong;WANG Qi-zhang

..............page:947-949

gu wai gu rou liu yi li
yin zuo ; luo de yun

..............page:949